Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI, USA.
Department of Neurology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109-5845, USA.
J Assist Reprod Genet. 2017 Nov;34(11):1529-1535. doi: 10.1007/s10815-017-1003-6. Epub 2017 Jul 28.
The purpose of this study is to examine the spectrum of infertility diagnoses and assisted reproductive technology (ART) treatments in relation to risk of preterm birth (PTB) in singletons.
Population-based assisted reproductive technology surveillance data for 2000-2010 were linked with birth certificates from three states: Florida, Massachusetts, and Michigan, resulting in a sample of 4,370,361 non-ART and 28,430 ART-related singletons. Logistic regression models with robust variance estimators were used to compare PTB risk among singletons conceived with and without ART, the former grouped by parental infertility diagnoses and treatment modalities. Demographic and pregnancy factors were included in adjusted analyses.
ART was associated with increased PTB risk across all infertility diagnosis groups and treatment types: for conventional ART, adjusted relative risks ranged from 1.4 (95% CI 1.0, 1.9) for male infertility to 2.4 (95% CI 1.8, 3.3) for tubal ligation. Adding intra-cytoplasmic sperm injection and/or assisted hatching to conventional ART treatment did not alter associated PTB risks. Singletons conceived by mothers without infertility diagnosis and with donor semen had an increased PTB risk relative to non-ART singletons.
PTB risk among ART singletons is increased within each treatment type and all underlying infertility diagnosis, including male infertility. Preterm birth in ART singletons may be attributed to parental infertility, ART treatments, or their combination.
本研究旨在探讨与单胎早产(PTB)相关的不孕诊断和辅助生殖技术(ART)治疗的范围。
将 2000-2010 年的基于人群的辅助生殖技术监测数据与来自佛罗里达州、马萨诸塞州和密歇根州的出生证明相联系,得到了 4370361 名非 ART 和 28430 名与 ART 相关的单胎样本。使用具有稳健方差估计的逻辑回归模型比较了非 ART 和 ART 单胎的 PTB 风险,前者按父母不孕诊断和治疗方式进行分组。调整后的分析包括人口统计学和妊娠因素。
ART 与所有不孕诊断组和治疗类型的 PTB 风险增加相关:对于常规 ART,男性不孕的调整相对风险范围为 1.4(95%CI 1.0, 1.9)至输卵管结扎的 2.4(95%CI 1.8, 3.3)。在常规 ART 治疗中添加胞浆内精子注射和/或辅助孵化并未改变相关的 PTB 风险。没有不孕诊断且使用供精的母亲所生的单胎与非 ART 单胎相比,PTB 风险增加。
在每种治疗类型和所有潜在的不孕诊断中,ART 单胎的 PTB 风险增加,包括男性不孕。ART 单胎的早产可能归因于父母不孕、ART 治疗或两者的结合。